Sfoglia per Rivista DIABETES, OBESITY AND METABOLISM
Age-dependent decline of beta-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
2014-01-01 Barker, A; Lauria, A; Schloot, N; Hosszufalusi, N; Ludvigsson, J; Mathieu, C; Mauricio, D; Nordwall, M; Van der Schueren, B; Mandrup-Poulsen, T; Scherbaum, Wa; Weets, I; Gorus, Fk; Wareham, N; Leslie, Rd; Pozzilli, P
Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study
2011-01-01 Palermo, A; Napoli, N; Manfrini, S; Lauria, A; Strollo, R; Pozzilli, P
Decline of neuroadrenergic bronchial innervation and respiratory function in type I diabetes mellitus: a longitudinal study
2007-01-01 Incalzi, R. A.; Fuso, L; Pitocco, D; Basso, S; Trovè, A; Longobardi, A; CALCAGNI M., L; Giordano, A; Ghirlanda, G; ANTONELLI INCALZI, RAFFAELE FRANCO
Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index
2019-01-01 Gentilella, R.; Sesti, G.; Vazquez, L.; Sapin, H.; Reed, V.; Romera, I.; Pozzilli, P
Dulaglutide Treatment Results in Effective Glycemic Control in Latent Autoimmune Diabetes in Adults (LADA): A Post-Hoc Analysis of the AWARD-2, -4, and -5 Trials
2018-01-01 Pozzilli, P; Leslie, Rd; Peters, Al; Buzzetti, R; Shankar, Ss; Milicevic, Z; Pavo, I; Lebrec, J; Martin, S; Schloot, Nc
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
2021-01-01 D'Onofrio, L; Pieralice, S; Maddaloni, E; Mignogna, C; Sterpetti, S; Coraggio, L; Luordi, C; Guarisco, G; Leto, G; Leonetti, F; Manfrini, S; Buzzetti, R.
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials
2023-01-01 Maddaloni, Ernesto; Cavallari, Ilaria; La Porta, Ylenia; Appetecchia, Alessandro; D'Onofrio, Luca; Grigioni, Francesco; Buzzetti, Raffaella; Holman, Rury R
Impact of obesity on the increasing incidence of type 1 diabetes.
2020-01-01 Buzzetti, R; Zampetti, S; Pozzilli, P
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)
2019-01-01 Maddaloni, E.; Coleman, R. L.; Pozzilli, P; Holman, R. R.
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
2017-01-01 Pozzilli, P; Norwood, P; Jódar, E; Davies, Mj; Ivanyi, T; Jiang, H; Woodward, Db; Milicevic, Z
Review of clinical trials: update on oral insulin spray formulation
2010-01-01 Pozzilli, P; Raskin, P; Parkin, Cg
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Age-dependent decline of beta-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study | 1-gen-2014 | Barker, A; Lauria, A; Schloot, N; Hosszufalusi, N; Ludvigsson, J; Mathieu, C; Mauricio, D; Nordwall, M; Van der Schueren, B; Mandrup-Poulsen, T; Scherbaum, Wa; Weets, I; Gorus, Fk; Wareham, N; Leslie, Rd; Pozzilli, P | |
| Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study | 1-gen-2011 | Palermo, A; Napoli, N; Manfrini, S; Lauria, A; Strollo, R; Pozzilli, P | |
| Decline of neuroadrenergic bronchial innervation and respiratory function in type I diabetes mellitus: a longitudinal study | 1-gen-2007 | Incalzi, R. A.; Fuso, L; Pitocco, D; Basso, S; Trovè, A; Longobardi, A; CALCAGNI M., L; Giordano, A; Ghirlanda, G; ANTONELLI INCALZI, RAFFAELE FRANCO | |
| Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index | 1-gen-2019 | Gentilella, R.; Sesti, G.; Vazquez, L.; Sapin, H.; Reed, V.; Romera, I.; Pozzilli, P | |
| Dulaglutide Treatment Results in Effective Glycemic Control in Latent Autoimmune Diabetes in Adults (LADA): A Post-Hoc Analysis of the AWARD-2, -4, and -5 Trials | 1-gen-2018 | Pozzilli, P; Leslie, Rd; Peters, Al; Buzzetti, R; Shankar, Ss; Milicevic, Z; Pavo, I; Lebrec, J; Martin, S; Schloot, Nc | |
| Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study | 1-gen-2021 | D'Onofrio, L; Pieralice, S; Maddaloni, E; Mignogna, C; Sterpetti, S; Coraggio, L; Luordi, C; Guarisco, G; Leto, G; Leonetti, F; Manfrini, S; Buzzetti, R. | |
| Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials | 1-gen-2023 | Maddaloni, Ernesto; Cavallari, Ilaria; La Porta, Ylenia; Appetecchia, Alessandro; D'Onofrio, Luca; Grigioni, Francesco; Buzzetti, Raffaella; Holman, Rury R | |
| Impact of obesity on the increasing incidence of type 1 diabetes. | 1-gen-2020 | Buzzetti, R; Zampetti, S; Pozzilli, P | |
| Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85) | 1-gen-2019 | Maddaloni, E.; Coleman, R. L.; Pozzilli, P; Holman, R. R. | |
| Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9). | 1-gen-2017 | Pozzilli, P; Norwood, P; Jódar, E; Davies, Mj; Ivanyi, T; Jiang, H; Woodward, Db; Milicevic, Z | |
| Review of clinical trials: update on oral insulin spray formulation | 1-gen-2010 | Pozzilli, P; Raskin, P; Parkin, Cg |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile